Global kidney function test market is projected to surpass around USD 765 Million mark by 2025, developing at around 5.9% CAGR during the forecast period.
The global kidney function test market is predicted to be valued at nearly 765 (USD Million) by 2025 and will grow at a CAGR of nearly 5.9% during the period from 2019 to 2025. The report offers valuation and analysis of the kidney function test market on a global as well as regional level. The study offers a comprehensive assessment of the industry competition, limitations, revenue estimates, avenues, current & emerging trends, and industry-validated market data. The report offers historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on value (USD Million).
Kidneys play a key role in the elimination of toxins like urea, serum osmolality, uric acid, creatinine, electrolyte concentration, and regulation of extracellular fluid volume. They produce hormones like 1,25 dihydroxyvitamin D, erythropoietin, and renin. Moreover, assessing kidney function is vital for effectively managing of patients impacted due to kidney disorders.
Key Growth Factors
The growth of the kidney function test market during the forecast timeline is attributed to the need for identifying kidney ailment, determining the kidney response to medical treatment, and evaluating the progress of the kidney disease. According to the NIH study, the global occurrence of chronic kidney disease is nearly 14% and the common causes of this disorder are high blood pressure and diabetes.
Furthermore, the tests for kidney function can be utilized for assessing the glomerular filtration rate. Moreover, the assessment of GFR or glomerular filtration rate is used for detecting the presence of the level of kidney impairment. Additionally, if the GFR is found to be reduced over a particular timespan or time interval, the physician can determine the chronic kidney disease phase.
Apparently, kidney function tests are used for knowing whether kidney disorder is chronic or not. In the case of urine albumin, the kidney function tests can also detect incipient nephropathy in patients mostly diabetics containing albumin in their urine. Apart from this, tubular function disorder like Fanconi syndrome can be identified through the kidney function tests through measuring levels of amino acids, pH, glucose, and phosphates in the urine of an individual. All these beneficial features of the renal function tests will steer the market growth over the forecast period.
Dipsticks Segment To Dominate Product Landscape By 2025
The segmental growth over 2019-2025 is attributed to the ability of the dipsticks to offer a qualitative analysis of myriad urine analytes. Apart from this, dipsticks have the ability to determine the presence of glucose, ketones, nitrite, blood, protein, leukocyte esterase, bilirubin, nitrite, and urobilinogen in urine. Moreover, urine testing through dipstick is cost-effective and hence has garnered massive popularity in the global kidney function test industry.
North American Market To Accumulate Humungous Gains Over 2019-2025
The regional market growth over the forecast timespan is credited to surge in the cases of chronic ailments, large-scale occurrence of high blood pressure, and rise in the presence of diabetics in the countries like the U.S. Apart from this, launching of new schemes by the government of Canada for creating awareness pertaining to the treatment of the kidney disorder will further embellish the market growth in the North American region.
Key players influencing the kidney function test industry and profiled in the report include Nova Biomedical Corporation, Siemens AG, URIT Medical Electronic Co., Ltd., Sysmex Corporation, Beckman Coulter Inc., ACON Laboratories, Inc., ARKRAY, Inc., Randox Laboratories, Roche Holding AG, Abbott Laboratories, OPTI Medical Systems, Inc., and 77 Elektronika Ltd.
|Historic Years||2016 - 2020|
|Forecast Years||2021 - 2028|
|Segments Covered||By Product Type, By Application, and By End Use|
|Forecast Units||Value (USD Billion), and Volume (Units)|
|Quantitative Units||Revenue in USD million/billion and CAGR from 2021 to 2028|
|Regions Covered||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World|
|Countries Covered||U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others|
|Number of Companies Covered||10 companies with scope for including additional 15 companies upon request|
|Report Coverage||Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.|
|Customization Scope||Avail customized purchase options to meet your exact research needs.|
The global kidney function test market is segmented as follows:
By End User
Request the coronavirus impact analysis across industries and markets